Toothpaste Regulation: How Ingredients and Marketing Claims Can Trigger Clinical Trial Requirement

Toothpaste is a product almost every American uses daily, but few consumers realize the regulatory complexity behind that familiar tube. If you’re a dental professional, product developer, or entrepreneur considering launching a new toothpaste, understanding the intersection of ingredients, marketing claims, and FDA requirements is crucial. In this comprehensive article, we’ll explore how both what’s in your toothpaste and what you say about it can mean the difference between a straightforward product launch and the need for rigorous, time-consuming clinical trials.

The Basics: How the FDA Classifies Toothpaste

The U.S. Food and Drug Administration (FDA) classifies products based on their intended use, which is determined by both their ingredients and the claims made on their labeling, advertising, and promotional materials. Toothpaste can fall into three regulatory categories:

• Cosmetic: Intended only to clean or beautify (e.g., “whitens teeth,” “freshens breath”).

• Drug: Intended to diagnose, cure, mitigate, treat, or prevent disease, or to affect the structure or function of the body (e.g., “prevents cavities,” “reduces plaque,” “fights gingivitis”).

• Both Cosmetic and Drug: Many toothpastes, such as those containing fluoride and claiming to prevent cavities, are regulated as both.

This distinction is not just academic, it determines everything from required testing to labeling, marketing, and whether you’ll need to conduct clinical trials before going to market.

Ingredients: The First Regulatory Trigger

The ingredients in your toothpaste are the first checkpoint for FDA scrutiny. If your product contains only cosmetic ingredients-those that clean, polish, or whiten teeth without affecting disease or body structure, it’s generally regulated as a cosmetic. In this case, you don’t need FDA premarket approval, nor are you required to conduct clinical trials, except for color additives.

However, if your toothpaste contains active ingredients that are intended to prevent or treat disease-such as fluoride for cavity prevention-it becomes an over-the-counter (OTC) drug under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FDA maintains a monograph (essentially a rulebook) for OTC anticaries (anti-cavity) toothpaste, specifying which ingredients are allowed, in what concentrations, and what claims can be made without additional approval.

If you stick to the monograph-using approved ingredients at approved concentrations and making only permitted claims-your product does not require a New Drug Application (NDA) or clinical trials. But if you use a novel ingredient, a new concentration, or make a claim not covered by the monograph, your toothpaste is classified as a “new drug.” In this case, you must submit an NDA, which requires robust clinical evidence of safety and efficacy-meaning clinical trials are mandatory before marketing.

Marketing Claims: The Second, Often Overlooked Trigger

Even if your toothpaste contains only cosmetic ingredients, what you say about it can instantly change its regulatory status. The FDA does not just look at the ingredient list; it scrutinizes all claims made on packaging, advertising, websites, and other promotional materials.

• Cosmetic Claims: Statements like “whitens teeth,” “freshens breath,” or “removes surface stains” are cosmetic. These claims do not require clinical trials or premarket approval.

• Drug Claims: Any statement that your toothpaste “prevents,” “treats,” or “reduces” disease-such as “prevents gingivitis,” “reduces plaque,” or “fights gum disease” is considered a drug claim. Even if your product contains only cosmetic ingredients, making these claims reclassifies your toothpaste as a drug in the eyes of the FDA.

This is where many companies get into trouble. You might have a perfectly safe, effective toothpaste, but if your marketing crosses the line into disease prevention or treatment, you’re suddenly required to meet all drug regulations-including clinical trial requirements for new drug claims.

The Role of Clinical Trials in Toothpaste Approval

If your toothpaste is classified as a drug, either because of its ingredients or its claims, you must prove to the FDA that it is both safe and effective for its intended use. For products covered by the OTC monograph, this has already been established for specific ingredients and claims, so no additional clinical trials are needed. But for new drugs, new claims, or new combinations, clinical trials are not optional - they’re mandatory.

Clinical trials must be designed to demonstrate that the toothpaste performs as claimed, under the conditions of use described on the label. This typically involves randomized, controlled studies with human subjects, measuring endpoints like reduction in plaque, prevention of gingivitis, or decrease in cavity formation. Only after submitting this data through an NDA process, and receiving FDA approval, can you legally market your toothpaste with those claims.

Examples: How Claims and Ingredients Interact

To illustrate how this works in practice, consider the following scenarios:

Scenario 1: Cosmetic Toothpaste

• Ingredients: Abrasives, flavoring, coloring agents (no fluoride or other active drug ingredients).

• Claims: “Whitens teeth,” “removes surface stains,” “freshens breath.”

• Regulatory Status: Cosmetic. No clinical trials or FDA premarket approval required.

Scenario 2: Standard Fluoride Toothpaste

• Ingredients: Contains sodium fluoride at concentrations approved in the FDA monograph.

• Claims: “Helps prevent cavities,” “anticavity toothpaste.”

• Regulatory Status: Both drug and cosmetic. Covered by the OTC monograph; no new clinical trials required if claims and ingredients match the monograph.

Scenario 3: Antiplaque/Anti-Gingivitis Toothpaste with New Ingredient

• Ingredients: Includes a novel antibacterial agent not listed in the monograph.

• Claims: “Reduces plaque,” “prevents gingivitis.”

• Regulatory Status: New drug. Requires NDA and clinical trials to prove safety and efficacy for these claims.

Scenario 4: Cosmetic Toothpaste with Disease Claims

• Ingredients: Only cosmetic.

• Claims: “Prevents gingivitis.”

• Regulatory Status: Drug, based on claims. Requires clinical trials, even if the ingredients themselves are not drugs.

The Importance of Intended Use and Labeling

The FDA’s determination of a product’s intended use is not limited to the ingredient list. Intended use can be established by:

• Claims on the label

• Advertising and promotional materials

• Statements by company representatives

• Consumer perception

If any of these suggest that your toothpaste is intended to prevent or treat disease, it will be regulated as a drug, regardless of its actual composition. This is why careful attention to marketing language is critical.

International Perspectives and Additional Considerations

Other countries have similar frameworks, though the details may differ. In the European Union and Canada, for example, toothpaste is also regulated based on both composition and claims, with strict requirements for labeling and permissible claims. In the U.K., for instance, fluoride-free toothpastes may be required to carry warnings and cannot make anti-cavity claims unless supported by evidence.

The Consequences of Non-Compliance

Marketing a toothpaste with unapproved drug claims or ingredients without the necessary clinical evidence can have serious consequences:

• FDA warning letters and enforcement actions

• Product recalls

• Fines and legal liability

• Damage to brand reputation

The FDA has a history of taking action against companies whose toothpaste products make unsubstantiated disease claims, even if those claims are only implied or appear in advertising rather than on the label.

How to Stay Compliant: Practical Steps

1. Review Your Ingredients: Ensure all active ingredients are either cosmetic or, if drug ingredients, are included in the FDA monograph at approved concentrations.

2. Audit Your Marketing Claims: Scrutinize every statement on your packaging, website, ads, and social media. Remove or reword any claim that could be interpreted as disease prevention or treatment unless you have clinical data and FDA approval to back it up.

3. Consult Regulatory Experts: If you’re unsure, consult with regulatory affairs professionals or legal counsel experienced in FDA compliance.

4. Monitor Regulatory Updates: FDA regulations and enforcement priorities can change. Stay informed about the latest developments in oral care product regulation.

Conclusion: Ingredients and Claims Both Matter

In the world of toothpaste regulation, both what’s inside the tube and what’s printed on the outside (and said in your ads) are equally important. Using drug ingredients or making disease-related claims can transform your product from a simple cosmetic into a regulated drug, triggering the need for clinical trials and FDA approval. Even if your formula is unchanged, a single marketing claim can bring on a host of new regulatory requirements.

For oral care entrepreneurs, dental professionals, and marketers, the takeaway is clear: compliance requires a holistic approach. Understand the FDA’s definitions, know your ingredients, and choose your words carefully. By doing so, you can avoid costly delays, regulatory headaches, and ensure your product reaches consumers safely and legally.

If you’re developing a new toothpaste or oral care product, always keep in mind that both your formulation and your marketing strategy must be developed with regulatory compliance in mind. The intersection of ingredients and claims is where most companies stumble-don’t let yours be one of them.

---

Howard Law is a business, regulatory and M&A law firm in the greater Charlotte, North Carolina area, with additional services in M&A advisory and business brokerage. Howard Law is a law firm based in the greater Charlotte, North Carolina area focused on business law, corporate law, regulatory law, mergers & acquisitions, M&A advisor and business brokerage. Handling all business matters from incorporation to acquisition as well as a comprehensive understanding in assisting through mergers and acquisition. The choice of a lawyer is an important decision and should not be based solely on advertisements. The information on this website is for general and informational purposes only and should not be interpreted to indicate a certain result will occur in your specific legal situation. Information on this website is not legal advice and does not create an attorney-client relationship. You should consult an attorney for advice regarding your individual situation. Contacting us does not create an attorney-client relationship. Please do not send any confidential information to us until such time as an attorney-client relationship has been established.